Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David C Fritzinger

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Hawaii Medical Journal|July 2, 2005
Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agentsDavid C Fritzinger
Current Pharmaceutical Design|November 6, 2007
Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletionCarl-Wilhelm Vogel, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology|April 27, 2010
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletionCarl-Wilhelm Vogel, David C Fritzinger
The Open Pain Journal|February 4, 2017
The Complement System in Neuropathic and Postoperative PainDavid C Fritzinger, Daniel E Benjamin
Molecular Immunology|July 27, 2014
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease modelsCarl-Wilhelm Vogel, Paul W Finnegan, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology|May 22, 2012
Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom FactorBrian E Hew, Daniel Wehrhahn, David C Fritzinger, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 18, 2019
Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteinsBrian E Hew, David C Fritzinger, Michael K Pangburn, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 12, 2020
Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stabilityBrian E Hew, Michael K Pangburn, Carl-Wilhelm Vogel, et al.
Thrombosis and Haemostasis|July 18, 2014
Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseasesCarl-Wilhelm Vogel, David C Fritzinger, W Brian Gorsuch, et al.
Molecular Immunology|May 26, 2004
Recombinant cobra venom factorCarl-Wilhelm Vogel, David C Fritzinger, Brian E Hew, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Hawaii Medical Journal|July 2, 2005
Cancer research center hotline: complement depletion: use of human C3/cobra venom factor (CVF) chimeric proteins as therapeutic agentsDavid C Fritzinger
Current Pharmaceutical Design|November 6, 2007
Humanized cobra venom factor: experimental therapeutics for targeted complement activation and complement depletionCarl-Wilhelm Vogel, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology|April 27, 2010
Cobra venom factor: Structure, function, and humanization for therapeutic complement depletionCarl-Wilhelm Vogel, David C Fritzinger
The Open Pain Journal|February 4, 2017
The Complement System in Neuropathic and Postoperative PainDavid C Fritzinger, Daniel E Benjamin
Molecular Immunology|July 27, 2014
Humanized cobra venom factor: structure, activity, and therapeutic efficacy in preclinical disease modelsCarl-Wilhelm Vogel, Paul W Finnegan, David C Fritzinger
Toxicon : Official Journal of the International Society on Toxinology|May 22, 2012
Hybrid proteins of Cobra Venom Factor and cobra C3: tools to identify functionally important regions in Cobra Venom FactorBrian E Hew, Daniel Wehrhahn, David C Fritzinger, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 18, 2019
Identification of functionally important amino acid sequences in cobra venom factor using human C3/Cobra venom factor hybrid proteinsBrian E Hew, David C Fritzinger, Michael K Pangburn, et al.
Toxicon : Official Journal of the International Society on Toxinology|June 12, 2020
Identification of intermolecular bonds between human factor B and Cobra Venom Factor important for C3 convertase stabilityBrian E Hew, Michael K Pangburn, Carl-Wilhelm Vogel, et al.
Thrombosis and Haemostasis|July 18, 2014
Complement depletion with humanised cobra venom factor: efficacy in preclinical models of vascular diseasesCarl-Wilhelm Vogel, David C Fritzinger, W Brian Gorsuch, et al.
Molecular Immunology|May 26, 2004
Recombinant cobra venom factorCarl-Wilhelm Vogel, David C Fritzinger, Brian E Hew, et al.
Pageof 2